Altmäe, Signe http://orcid.org/0000-0002-0708-1865
Koel, Mariann
Võsa, Urmo
Adler, Priit
Suhorutšenko, Marina
Laisk-Podar, Triin
Kukushkina, Viktorija
Saare, Merli
Velthut-Meikas, Agne
Krjutškov, Kaarel
Aghajanova, Lusine
Lalitkumar, Parameswaran G.
Gemzell-Danielsson, Kristina
Giudice, Linda
Simón, Carlos
Salumets, Andres
Article History
Received: 7 November 2016
Accepted: 28 July 2017
First Online: 30 August 2017
Competing Interests
: Prof. Carlos Simón is the Chief Scientific Officer of Igenomiz, a Biotec Company that commercialize the ERA test. All the rest of the authors declare no competing financial interests.